Industrial • NYSE
According to Zyberno, Arcosa, Inc. (ACA) is not a buy — AVERAGE BUSINESS (56/100) with a negative Margin of Safety of +4.0% and a Brina Gap of -15.2% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, Arcosa, Inc. (ACA) trades at $145.28 against an estimated intrinsic value per share of $151.40 — a +4.0% Margin of Safety based on Owner Earnings of $245.70M TTM, projected at 19.4% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -15.2% weakens the case: based on the company's ROIC (6.5%) and reinvestment rate (-28.5%), the business can fundamentally grow at -1.9% — but the current enterprise value implies the market expects 13.3%. This places ACA in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of 20.4% annually.
Over the trailing twelve months, ACA generated $245.70M in Owner Earnings. Capital was deployed as follows: $17.50M returned via share buybacks, $9.90M paid as dividends, $175.10M invested in capital expenditures. Reinvestment rate: -28.5%. Owner Earnings have grown at 19.4% annually over the trailing five years using log-linear regression.